Hillgene
hillgene.com
Actively hiring
Cell & Gene Therapy
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2017
Founded
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Anocca is creating a pipeline of precision T-cell immunotherapies by combining its novel approach to T-cell biology, cutting-edge…
Q-Immune provides cutting-edge real-time protein network analysis for CAR-T cells, enabling accurate efficacy prediction, optimized CAR-T…
Next-generation CAR T-cell therapies engineered to disrupt the tumor microenvironment OUR MISSION CARTemis Therapeutics is a clinical-stage…
Accelerate cancer immunotherapy and cancer vaccine development with Alithea Bio's HLA immunopeptidomics platform — neoantigen discovery…
Learn about Lyell and how we are building an industry-leading clinical-stage pipeline of CAR-T cell product candidates for cancer.
Optieum Biotechnologies is a biotechnology company that generates optimised scFvs to yield CAR-T cells with a strong anti-tumor effect. Its…
Overview
苏州市吴中区吴中大道1463号越旺智慧谷A4号楼 400-900-1882 [email protected] 关于谱新 专注的细胞药物解决方案提供商 公司介绍 谱新生物，定位为全球细胞药物整体解决方案提供商，中国总部位于美丽的太湖之滨苏州市吴中区，拥有苏州总部（10000㎡GMP厂房和研发中心），欧洲总部位于欧洲比利时瓦隆大区列日市，实现了细胞制剂全球供应。谱新生物聚焦细胞药物领域，搭建了针对CAR-T、TCR-T、CAR-NK、TIL、HSC等不同的细胞药物类型建立了专用的HiPlasTM载体系统、HiLenti®悬浮无血清病毒生产平台和HiCellx…
Financials
Investors
8
Key Investors
湖南高创海盈医疗健康产业投资合伙企业（有限合伙）
shareholder on the register (清科 zdb)
湖南健康养老产业投资基金企业（有限合伙）
shareholder on the register (清科 zdb)
共青城正旭三号股权投资合伙企业（有限合伙）
shareholder on the register (清科 zdb)
北京国科鼎智股权投资中心（有限合伙）
shareholder on the register (清科 zdb)
深圳市远致创业投资有限公司
shareholder on the register (清科 zdb)
中小企业发展基金（深圳有限合伙）
shareholder on the register (清科 zdb)
潍坊圣者股权投资管理合伙企业（有限合伙）
shareholder on the register (清科 zdb)
深圳润信新观象战略新兴产业私募股权投资基金合伙企业（有限合伙）
shareholder on the register (清科 zdb)